Arti Rai, Elvin R. Latty Professor of Law and co-Director, The Center for Innovation Policy at Duke Law, is an internationally recognized expert in intellectual property (IP) law, innovation policy, administrative law, and health law. Rai has also taught at Harvard, Yale, and the University of Pennsylvania Law Schools. Rai's research on innovation law and policy in biotechnology, pharmaceuticals, and software has been funded by NIH, the Kauffman Foundation, and the Woodrow Wilson Center. Her numerous publications have appeared in both peer-reviewed journals and law reviews, including Science, the New England Journal of Medicine, the Journal of Legal Studies, Nature Biotechnology, and the Columbia, Duke, University of Pennsylvania, University of Texas, Georgetown, and Northwestern law reviews. She is the editor of Intellectual Property Law and Biotechnology: Critical Concepts (Edward Elgar, 2011) and the co-author of a 2012 Kauffman Foundation monograph on cost-effective health care innovation. Rai’s current work focuses on theoretical and empirical analyses of patent eligibility doctrine and on patent institutions, including the Patent Trial and Appeals Board created by the America Invents Act of 2011.
Rai AK, Sachs R, II WN. Cryptic Patent Reform Through the Inflation Reduction Act (Accepted). Harvard Journal of Law & Technology. 2023;
Rai AK. What Does ‘Bona Fide Competition’ Actually Mean in the Biologics Market? Stat. 2023.
Rai AK, Vishnubhakat S, Lemus J, Hovenkamp E. Post-Grant Adjudication of Drug Patents: Agency and/or Court? Berkeley Technology Law Journal. 2022;37(1):139–69.